NCT06852742 is a NA clinical trial of Facial Cream A in Photodamaged Skin, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).

Who is sponsoring NCT06852742?

NCT06852742 is sponsored by Johnson & Johnson Consumer Inc. (J&JCI).

What drugs are being tested in NCT06852742?

Interventions in NCT06852742: Facial Cream A, Facial Cream B.

What condition does NCT06852742 study?

NCT06852742 studies Photodamaged Skin.

Is NCT06852742 still recruiting?

NCT06852742 is currently completed. Last updated 4 July 2025.

Last reviewed 2025-07-04 · How we verify

NCT06852742

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study to Evaluate and Compare the Efficacy of Two Facial Creams on Moderately to Severely Photodamaged Skin

Completed NA Last updated 4 July 2025

What this trial tests

NA trial testing Facial Cream A in Photodamaged Skin in 69 participants. Completed in 1 May 2025.

Timeline

20 January 2025

Primary endpoint
1 May 2025

1 May 2025

Quick facts

Lead sponsor	Johnson & Johnson Consumer Inc. (J&JCI)
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	basic science
Enrollment	69
Start date	20 January 2025
Primary completion	1 May 2025
Estimated completion	1 May 2025
Sites	1 location across United States

Drugs / interventions tested

Facial Cream A
Facial Cream B

Conditions studied

Photodamaged Skin — all drugs for Photodamaged Skin →

Sponsor

Johnson & Johnson Consumer Inc. (J&JCI) — full company profile →

Who can join

Adults 35 to 60, female only, with Photodamaged Skin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate the efficacy of a retinol alternative-containing facial cream in improving skin texture, radiance/brightness, and the appearance of fine lines, wrinkles, uneven skin tone, and dark spots, with a positive control of a retinol-containing cream.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Johnson & Johnson Consumer Inc. (J&JCI) trials

Trials by the same sponsor.

NCT06734299 — A Study to Evaluate Usage of Mineral Sunscreens With Differentiated Whitening Attributes in Multi-Cultural Skin Tones · NA · completed
NCT06658847 — A Study to Evaluate the Effect of a Topical Retinol on Epigenetic Changes and Expression of Certain Genes in the Skin Us · NA · completed
NCT06654102 — A Study to Evaluate the Cutaneous Effects of Deep Ultraviolet A +/- High-Energy Visible Blue Light Exposure · NA · completed
NCT06318637 — Evaluation of the Acceptability and Feasibility of a Bedtime Routine for Neonates · NA · completed
NCT05845008 — A Multiple-Dose Safety Study of Fixed Combination of Acetaminophen/Naproxen Sodium in Adolescents With Orthodontic Pain · Phase 3 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06852742 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Consumer Inc. (J&JCI)
Last refreshed: 4 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06852742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing